These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8058084)

  • 1. Adjuvant therapy for breast cancer.
    Melnychuk D; Panasci LC
    N Engl J Med; 1994 Sep; 331(11):741-2; author reply 744-5. PubMed ID: 8058084
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor angiogenesis in women with node-positive breast cancer.
    Folkman J
    Cancer J Sci Am; 1995; 1(2):106-8. PubMed ID: 9166461
    [No Abstract]   [Full Text] [Related]  

  • 3. [Adjuvant therapy of breast cancer].
    Semiglazov VF; Abzumanov AS; Bozhok AA; Ivanov VG; Ivanova OA; Barash NIu; Topuzov EE; Seleznev IK; Migmanova NSh; Popova RT; Nurgaziev KSh
    Khirurgiia (Mosk); 2001; (5):52-60. PubMed ID: 11505673
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor angiogenesis predicts clinical outcome of node-positive breast cancer patients treated with adjuvant hormone therapy or chemotherapy.
    Gasparini G; Barbareschi M; Boracchi P; Verderio P; Caffo O; Meli S; Dalla Palma P; Marubini E; Bevilacqua P
    Cancer J Sci Am; 1995; 1(2):131-41. PubMed ID: 9166466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of 5-fluorouracil-related genes in breast cancer to predict the effect of adjuvant therapy with CMF].
    Tsunoda Y; Suzuki K; Sakamoto MA; Date Y; Sawada T; Tsunoda A; Kusano M
    Gan To Kagaku Ryoho; 2009 Jan; 36(1):51-5. PubMed ID: 19151563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical management of breast cancer.
    Crown JP; Fennelly JJ
    Ir Med J; 1993; 86(5):143-5. PubMed ID: 8225913
    [No Abstract]   [Full Text] [Related]  

  • 7. [Consensus and controversy in adjuvant treatment indications in breast cancers].
    Rouëssé J
    Pathol Biol (Paris); 1990 Oct; 38(8):846-7. PubMed ID: 2274383
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparison of epirubicin and cyclophosphamide in 2-dose levels and classical CMF protocol in node-positive breast cancer. An adjuvant Phase III trial].
    Ost E; Illiger HJ
    Strahlenther Onkol; 2002 Jan; 178(1):54-5. PubMed ID: 11977396
    [No Abstract]   [Full Text] [Related]  

  • 9. Paradigm shift in adjuvant treatment of receptor positive premenopausal breast cancer patients? Not yet!
    Samur M; Bozcuk HS
    J Clin Oncol; 2003 Jun; 21(12):2444; author reply 2445-7. PubMed ID: 12805349
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prognostic factors in lymph node negative breast cancer].
    Kleeberg UR
    Strahlenther Onkol; 2002 Jan; 178(1):53-4. PubMed ID: 11977395
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: a report from the National Cancer Institute of Canada Clinical Trials Group.
    Crump M; Tu D; Shepherd L; Levine M; Bramwell V; Pritchard K
    J Clin Oncol; 2003 Aug; 21(16):3066-71. PubMed ID: 12915595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prospective randomized trial on the efficacy of adjuvant endocrine therapy for ER-positive breast cancer patients after radical mastectomy].
    Jiang Z; Song S; Liu X
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):420-2. PubMed ID: 11810777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Benefits of adjuvant chemotherapy for breast cancer].
    Motomura K; Noguchi S; Inaji H; Koyama H
    Gan To Kagaku Ryoho; 1997 Aug; 24(10):1239-44. PubMed ID: 9279342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons from the initial adjuvant cyclophosphamide, methotrexate, and fluorouracil studies in operable breast cancer.
    Bonadonna G; Valagussa P; Veronesi U
    J Clin Oncol; 2008 Jan; 26(3):342-4. PubMed ID: 18202404
    [No Abstract]   [Full Text] [Related]  

  • 15. [Quality outcome of adjuvant CMF therapy in patients with breast cancer].
    Kleeberg UR
    Strahlenther Onkol; 2000 Jun; 176(6):290-1. PubMed ID: 10897257
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of the outcomes of non-randomised chemotherapy regimens in node positive breast cancer.
    Kuru B; Camlibel M; Dinc S; Gulcelik MA; Atalay C; Alagol H
    J Exp Clin Cancer Res; 2005 Sep; 24(3):363-72. PubMed ID: 16270522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying good prognosis group of breast cancer patients with 1-3 positive axillary nodes for adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF) chemotherapy.
    Lin YC; Chen SC; Chang HK; Hsueh S; Tsai CS; Lo YF; Hwang TL; Chen MF
    Jpn J Clin Oncol; 2005 Sep; 35(9):514-9. PubMed ID: 16199422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of chemotherapy preceding exclusive conservative loco-regional radiotherapy in breast cancer].
    Baillet F; Housset M; Khayat D; Rozec C; Ucla L; Maulard C; Brunel P; Hu BQ; Delanian S
    Pathol Biol (Paris); 1992 Nov; 39(9):933-4. PubMed ID: 1538940
    [No Abstract]   [Full Text] [Related]  

  • 19. [Radiation and concomitant chemotherapy after surgery for breast cancer].
    Calais G
    Cancer Radiother; 2004 Feb; 8(1):39-47. PubMed ID: 15093200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recent advance in adjuvant therapy for breast cancer].
    Shimizu C; Watanabe T
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2458-69. PubMed ID: 12506467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.